PrimeRFP SCOUT · Federal Contract Recompete Brief

80ARC022CA004Identification of biomarkers and pathological — Icahn School of Medicine at Mount Sinai

Icahn School of Medicine at Mount Sinai holds $259.7M across 47 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. Competition previously drew 9 offers. Set-aside status: Unrestricted. Recompete timing centers on the Sep 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Nasa Ames Research Center
Awarding office
Icahn School of Medicine at Mount Sinai
Recipient
Sep 29, 2027
PoP end
$5.5M
Obligated
$6.3M
Potential
541715
NAICS
AR11
PSC
Unrestricted
Set-aside
9 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number80ARC022CA004
AgencyNasa Ames Research Center
Awarding officeNasa Ames Research Center
Awarding agencyNational Aeronautics and Space Administration (NASA)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentIcahn School of Medicine at Mount Sinai
CAGE1QSQ9
UEIC8H9CNG1VBD9
NAICS541715
PSCAR11
Place of performanceNEW YORK NY
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
Related solicitationNNH21ZDA015N
PoP startSep 28, 2022
PoP end (current)Sep 29, 2027
Obligated$5.5M
Current value$6.3M
Potential value$6.3M

IDENTIFICATION OF BIOMARKERS AND PATHOLOGICAL MECHANISMS VIA LONGITUDINAL ANALYSIS OF NEUROLOGICAL AND CEREBROVASCULAR RESPONSES TO NEUROTOXIC STRESS USING A MULTI-CELLULAR INTEGRATED MODEL OF THE HUMAN BRAIN is a federal Unrestricted award for Nasa Ames Research Center held by Icahn School of Medicine at Mount Sinai. Estimated value $6.3M ($5.5M obligated). Current period of performance ends Sep 29, 2027. Last award drew 9 bidders. Place of performance: NEW YORK NY. Related solicitation NNH21ZDA015N.

IDENTIFICATION OF BIOMARKERS AND PATHOLOGICAL MECHANISMS VIA LONGITUDINAL ANALYSIS OF NEUROLOGICAL AND CEREBROVASCULAR RESPONSES TO NEUROTOXIC STRESS USING A MULTI-CELLULAR INTEGRATED MODEL OF THE HUMAN BRAIN

Recompete timing

Public
● Expiring in 361 days

Current PoP ends Sep 29, 2027 (361 days remaining). Agencies typically plan 12–18 months ahead — at 11.9 months out, that window is already open. The buying decision is likely already in motion.

Want the durability read on 80ARC022CA004? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Icahn School of Medicine at Mount Sinai — $259.7M obligated across 47 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($259.7M) · all agencies
Department of Health and Human Services (HHS)$250.9M · 97%National Aeronautics and Space Administration (NASA)$4.0M · 2%Department of Veterans Affairs (VA)$2.9M · 1%Department of Defense (DOD)$1.9M · 1%
Open full company profile →

Related awards

Same incumbent
36C24226N0420
TRANSPLANT SURGEONS
$467K
Mar 31, 2027
36C24226N0443
LIVING DONOR EVALUATIONS AND SURGERY FOR THE VA
$166K
Mar 31, 2027
75N93019C00051
THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION C…
$111.2M
Jul 9, 2027
75D30122C15187
DATA CENTER 2 - ISMMS
$25.1M
Sep 28, 2027
36C24E22C0034
BRAIN BANK
$510K
Sep 29, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 80ARC022CA004?

80ARC022CA004 (Identification of biomarkers and pathological) is a Nasa Ames Research Center award with a potential value of $6.3M, currently held by Icahn School of Medicine at Mount Sinai. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 80ARC022CA004?

Nasa Ames Research Center awarded 80ARC022CA004 to Icahn School of Medicine at Mount Sinai (potential $6.3M).

Who is the incumbent on 80ARC022CA004?

Icahn School of Medicine at Mount Sinai is the incumbent with $259.7M across 47 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2027.

When does Icahn School of Medicine at Mount Sinai’s 80ARC022CA004 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 80ARC022CA004? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/80ARC022CA004